MedPath

Comparison of the effect of pomegranate juice with sildenafil in the treatment of intrauterine growth restrictio

Phase 3
Conditions
Fetal growth restriction.
O36.5
Maternal care for known or suspected poor fetal growth
Registration Number
IRCT20210730052014N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
54
Inclusion Criteria

No underlying diseases
gestational age 26 to 32 weeks
fetal developmental delay
singleton cases
willingness to participate in the study

Exclusion Criteria

fetal anomalies and fetal heart problems
consumption of antioxidants and special diets

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fetal growth restriction. Timepoint: At the beginning of the study and then monthly. Method of measurement: Changes in umbilical artery PI, uterine artery PI, and estimated fetal weight (FEW) in both groups are monitored and compared monthly by a female resident alongside a perinatologist and radiologist with a Medison device.
Secondary Outcome Measures
NameTimeMethod
Birth weight of the baby. Timepoint: At birth. Method of measurement: Using digital scales.;Apgar score. Timepoint: At birth. Method of measurement: cheaklist.
© Copyright 2025. All Rights Reserved by MedPath